Australia is closely watching the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist , representing a potential advance in weight loss . Early study data have demonstrated impressive results, https://safamldi047206.imblogs.net/93685816/retatrutide-in-australia-a-new-solution-for-weight-loss